Dexcom (DXCM) Short-term Investments (2010 - 2025)

Dexcom (DXCM) has 16 years of Short-term Investments data on file, last reported at $1.8 billion in Q1 2025.

• On a quarterly basis, Short-term Investments fell 12.19% year-over-year to $1.8 billion in Q1 2025; TTM through Mar 2025 was $1.8 billion, a 12.19% decrease from a year earlier, with the FY2024 full-year figure at $2.0 billion, down 8.55% from the prior year.
• Short-term Investments for Q1 2025 stood at $1.8 billion, down from $2.0 billion in the prior quarter.
• Over the last five years, Short-term Investments for DXCM reached as high as $2.6 billion in Q3 2023 and fell as low as $1.3 billion in Q3 2021.
• Historically, Short-term Investments has averaged $1.9 billion across 5 years, with a median of $1.9 billion in 2023.
• On a YoY basis, Short-term Investments climbed as much as 105.08% in 2021 and fell as far as 35.06% in 2021.
• Year by year, Short-term Investments stood at $1.7 billion in 2021, then gained by 8.06% to $1.8 billion in 2022, then grew by 18.96% to $2.2 billion in 2023, then decreased by 8.55% to $2.0 billion in 2024, then decreased by 8.96% to $1.8 billion in 2025.
• Per Business Quant data, the three most recent Short-term Investments figures were $1.8 billion in Q1 2025, $2.0 billion in Q4 2024, and $1.9 billion in Q3 2024.